Main Menu

The Dun & Bradstreet Corporation

(NYSE: DNB)

Summary

Attention investors who purchased shares of The Dun & Bradstreet Corporation before August 9, 2018:

Rigrodsky & Long is investigating potential claims against the board of directors of The Dun & Bradstreet Corporation concerning possible breaches of fiduciary duty and other violations of law related to the Company’s agreement to be acquired by a consortium including Cannae Holdings, Inc. for $145.00 per share, or approximately $6.9 billion.

Press Release

Rigrodsky & Long, P.A. announces that it is investigating potential legal claims against the board of directors of The Dun & Bradstreet Corporation (“Dun & Bradstreet” or the “Company”) (NYSE: DNB) regarding possible breaches of fiduciary duties and other violations of law related to the Company’s entry into an agreement to be acquired by a consortium including CC Capital, Thomas H. Lee Partners, and Cannae Holdings, Inc. (NYSE: CNNE) in a transaction valued at approximately $6.9 billion.  Under the terms of the agreement, shareholders of Dun & Bradstreet will receive $145.00 in cash for each share of Dun & Bradstreet common stock.   

If you own common stock of Dun & Bradstreet and purchased any shares before August 9, 2018, if you would like to learn more about this investigation, or if you have any questions concerning this announcement or your rights or interests, please contact Seth D. Rigrodsky or Gina M. Serra at Rigrodsky & Long, P.A., 300 Delaware Avenue, Suite 1220, Wilmington, Delaware 19801, by telephone at (888) 969-4242, or by e-mail at info@rl-legal.com.  

Rigrodsky & Long, P.A., with offices in Wilmington, Delaware, Garden City, New York, and San Francisco, California, has recovered hundreds of millions of dollars on behalf of investors and achieved substantial corporate governance reforms in numerous cases nationwide, including federal securities fraud actions, shareholder class actions, and shareholder derivative actions.

Attorney advertising.  Prior results do not guarantee a similar outcome.

Back to Page